Crealogix Holding AG
SIX:CLXNE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Crealogix Holding AG
SIX:CLXNE
|
CH |
|
Rukun Raharja Tbk PT
IDX:RAJA
|
ID |
|
Takeda Pharmaceutical Co Ltd
F:TKD
|
JP |
|
O
|
Organon & Co
XBER:7XP
|
US |
|
A
|
AB Science SA
F:A8D
|
FR |
|
N
|
NU Skin Enterprises Inc
XBER:NUS
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLXNE's stock price target?
Not Available
CLXNE does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Crealogix Holding AG?
Projected CAGR
6%
Over the last 8 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Crealogix Holding AG?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 3 years is 31%.
What is the Net Income forecast for Crealogix Holding AG?
Projected CAGR
596%
The compound annual growth rate for Net Income over the next 3 years is 596%.